This small-cap stock surged 75% since IPO price but ICICI Securities sets target below CMP; what should shareholders do?

Sudeep Pharma shares have surged nearly 75% above their IPO price, but ICICI Securities retained its Hold rating and raised its target price to ₹1,000, citing expectations for its emerging battery materials business.